Primary Distal Renal Tubular Acidosis

Clinical Research/Studies

Are there any clinical trials for primary distal renal tubular acidosis?

As of November 2018, there is one clinical trial listed on sponsored by Advicenne Pharma for primary distal renal tubular acidosis. This study is examining the safety and effectiveness of an extended release form of alkali therapy (ADV7103) in maximizing alkali therapy over a 12-hour period and decreasing treatment to twice a day.

If future clinical trials occur, they must be registered on too. Individuals interested in participating in clinical research studies should visit the site regularly, as studies can appear or change enrollment status frequently.

Antidote also offers a handy tool to find clinical trials.

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more about our use of cookies and similar technology

This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Remember Me